ONCrg Live Event: WCLC Insights into ESMO Signals
Join our team as we break down the major readouts shaping thoracic oncology, including:
- 1L EGFR ex20ins+ NSCLC: First Phase III data for zipalertinib
- TKI-Naive ROS1+ NSCLC: Potentially registrational data for zidesamtinib
- 1L HER2m+ NSCLC: First Phase III data readout for T-DXd
- Relapsed SCLC: First CN Phase III data on two B7-H3 ADCs (tambotatug pelitecan and risvutatug rezetecan)
Plus, we’ll dive into early signals to track as attention shifts toward ESMO 2026.
👉 What specific topics or questions are you hoping we cover during the live event? Let us know when you register for the event!
- SCLC
- WCLC 2026
- ESMO 2026
- NSCLC
- Oncology Intelligence
- +2